A 58-year-old man with newly diagnosed pancreatic cancer presents to the emergency department with acute onset of severe headache, confusion, and dyspnea. On examination: temperature 38.2°C, BP 100/65 mmHg, respiratory rate 28/min. Laboratory results: hemoglobin 7.8 g/dL, platelet count 45,000/μL, PT 18 seconds (normal 11–13.5 s), aPTT 48 seconds (normal 24–35 s), fibrinogen 85 mg/dL (normal 200–400 mg/dL), D-dimer 8.5 μg/mL (normal <0.5 μg/mL). Blood smear shows schistocytes. Which of the following is the most appropriate immediate management?

Explanation

## Clinical Diagnosis: Disseminated Intravascular Coagulation (DIC) Secondary to Pancreatic Cancer ### Diagnostic Criteria Met **Key Point:** This patient meets the International Society on Thrombosis and Haemostasis (ISTH) criteria for **overt DIC**: - Severe thrombocytopenia (45,000/μL) - Prolonged PT (18 s) and aPTT (48 s) - Markedly decreased fibrinogen (85 mg/dL — normal 200–400 mg/dL) - Markedly elevated D-dimer (8.5 μg/mL — normal <0.5 μg/mL) - Schistocytes on blood smear (microangiopathic hemolytic anemia from fibrin strand-mediated RBC destruction) - Anemia (Hb 7.8 g/dL) - Underlying malignancy (pancreatic cancer) — a classic trigger for DIC ### DIC vs. TTP: Critical Differentiator | Feature | **DIC (this patient)** | **TTP** | |---------|----------------------|---------| | PT/aPTT | **Prolonged** | Normal | | Fibrinogen | **↓↓ (85 mg/dL)** | Normal | | D-dimer | **↑↑↑** | Normal/mildly ↑ | | Schistocytes | Present | Present | | Platelet count | ↓↓ | ↓↓ | | Trigger | Malignancy, sepsis, trauma | Idiopathic, ADAMTS13 deficiency | **High-Yield:** The **combination of prolonged PT/aPTT + low fibrinogen + markedly elevated D-dimer** unequivocally identifies this as DIC, NOT TTP. TTP characteristically has **normal coagulation studies and normal fibrinogen**. This distinction is fundamental in NEET PG/AIIMS examination doctrine. ### Why Fresh Frozen Plasma + Platelet Transfusion Is Correct **Clinical Pearl (Harrison's Principles of Internal Medicine):** In overt DIC with active bleeding or organ dysfunction, the immediate management is **replacement of consumed clotting factors and platelets**: 1. **Fresh Frozen Plasma (FFP):** Contains all clotting factors (I, II, V, VII, VIII, IX, X, XI). Corrects the prolonged PT and aPTT by replenishing factors consumed in the DIC process. Dose: 15–20 mL/kg. 2. **Platelet transfusion:** Indicated when platelet count <50,000/μL with active bleeding or clinical deterioration. Target >50,000/μL in bleeding patients. 3. **Treat the underlying cause:** Definitive management of DIC requires addressing the trigger (pancreatic cancer, sepsis, etc.). This patient has active organ dysfunction (neurological symptoms, respiratory distress, hemodynamic instability — BP 100/65 mmHg), making immediate supportive replacement therapy essential. ### Why Other Options Are Wrong **Option B — Cryoprecipitate and fibrinogen concentrate:** Cryoprecipitate is rich in fibrinogen, Factor VIII, vWF, and Factor XIII, and is used as an *adjunct* when fibrinogen is critically low (<100 mg/dL). However, it does not correct the full coagulopathy (prolonged PT/aPTT) and is not the *most appropriate immediate* first-line management compared to FFP + platelets, which address the broader coagulation defect. **Option C — Plasma exchange (therapeutic plasma exchange):** Plasma exchange is the **standard of care for TTP** (removes anti-ADAMTS13 antibodies, replenishes ADAMTS13 enzyme). It is **NOT indicated for DIC**. This patient's laboratory profile — prolonged PT/aPTT and low fibrinogen — definitively excludes TTP and confirms DIC. Plasma exchange in DIC is not supported by evidence and is not standard teaching per Harrison's or ISTH guidelines. **Option D — Heparin and warfarin anticoagulation:** Anticoagulation is **not first-line** for DIC. Heparin may be considered in a narrow subset of DIC with predominant thrombosis (e.g., purpura fulminans, acral ischemia) after fibrinogen is corrected, but is contraindicated in bleeding DIC. Warfarin has no role in acute DIC management. **High-Yield Summary:** DIC = prolonged PT/aPTT + low fibrinogen + high D-dimer → manage with FFP + platelets + treat underlying cause. TTP = normal coagulation + normal fibrinogen + schistocytes → manage with plasma exchange. Never confuse these two entities in examination settings. *Reference: Harrison's Principles of Internal Medicine, 21st edition, Chapter on Coagulation Disorders; ISTH DIC Scoring System.*